REPR Insider Trading Activity and SEC Form 4 Filings
REPR insider trading summary
No open-market insider purchases or sales of Repro Med Systems Inc (REPR) have been reported on SEC Form 4 in the past 12 months.
Latest REPR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 14, 2019 | Horton Capital Management, LLC | 10% Owner | Buy | $13K (5,847 @ $2.20) |
| Jun 14, 2019 | Joseph M. Manko Jr. | Director | Buy | $13K (5,847 @ $2.20) |
| Jun 14, 2019 | Horton Capital Partners, LLC | 10% Owner | Buy | $13K (5,847 @ $2.20) |
| Jun 14, 2019 | Horton Capital Partners Fund, L.P. | 10% Owner | Buy | $13K (5,847 @ $2.20) |
| Jun 13, 2019 | Horton Capital Management, LLC | 10% Owner | Buy | $4K (2,000 @ $2.11) |
| Jun 13, 2019 | Horton Capital Partners Fund, L.P. | 10% Owner | Buy | $4K (2,000 @ $2.11) |
| Jun 13, 2019 | Horton Capital Partners, LLC | 10% Owner | Buy | $4K (2,000 @ $2.11) |
| Jun 13, 2019 | Joseph M. Manko Jr. | Director | Buy | $4K (2,000 @ $2.11) |
| Mar 15, 2019 | James M Beck | Director | Buy | $54K (35,000 @ $1.55) |
| Mar 5, 2019 | Arthur J Radin | Director | Buy | $23K (15,000 @ $1.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.